nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Nephropathy toxic—Cisplatin—bone cancer	0.0372	0.0372	CcSEcCtD
Ceftibuten—Body temperature increased—Carboplatin—bone cancer	0.0205	0.0205	CcSEcCtD
Ceftibuten—Aphasia—Methotrexate—bone cancer	0.0181	0.0181	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Cisplatin—bone cancer	0.0172	0.0172	CcSEcCtD
Ceftibuten—Nasal congestion—Cisplatin—bone cancer	0.017	0.017	CcSEcCtD
Ceftibuten—Irritability—Cisplatin—bone cancer	0.0148	0.0148	CcSEcCtD
Ceftibuten—Dehydration—Cisplatin—bone cancer	0.0144	0.0144	CcSEcCtD
Ceftibuten—Rigors—Epirubicin—bone cancer	0.0134	0.0134	CcSEcCtD
Ceftibuten—Pancytopenia—Cisplatin—bone cancer	0.0127	0.0127	CcSEcCtD
Ceftibuten—Rigors—Doxorubicin—bone cancer	0.0124	0.0124	CcSEcCtD
Ceftibuten—Renal failure—Cisplatin—bone cancer	0.0117	0.0117	CcSEcCtD
Ceftibuten—Vaginal inflammation—Methotrexate—bone cancer	0.0117	0.0117	CcSEcCtD
Ceftibuten—Melaena—Methotrexate—bone cancer	0.0114	0.0114	CcSEcCtD
Ceftibuten—Vaginal infection—Methotrexate—bone cancer	0.0111	0.0111	CcSEcCtD
Ceftibuten—Aplastic anaemia—Methotrexate—bone cancer	0.011	0.011	CcSEcCtD
Ceftibuten—Vaginal inflammation—Epirubicin—bone cancer	0.011	0.011	CcSEcCtD
Ceftibuten—Eructation—Epirubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Ceftibuten—Melaena—Epirubicin—bone cancer	0.0107	0.0107	CcSEcCtD
Ceftibuten—Candida infection—Epirubicin—bone cancer	0.0105	0.0105	CcSEcCtD
Ceftibuten—Vaginal infection—Epirubicin—bone cancer	0.0104	0.0104	CcSEcCtD
Ceftibuten—Aplastic anaemia—Epirubicin—bone cancer	0.0103	0.0103	CcSEcCtD
Ceftibuten—Vaginal inflammation—Doxorubicin—bone cancer	0.0101	0.0101	CcSEcCtD
Ceftibuten—Eructation—Doxorubicin—bone cancer	0.00997	0.00997	CcSEcCtD
Ceftibuten—Melaena—Doxorubicin—bone cancer	0.00991	0.00991	CcSEcCtD
Ceftibuten—Candida infection—Doxorubicin—bone cancer	0.00969	0.00969	CcSEcCtD
Ceftibuten—Vaginal infection—Doxorubicin—bone cancer	0.00958	0.00958	CcSEcCtD
Ceftibuten—Aplastic anaemia—Doxorubicin—bone cancer	0.00953	0.00953	CcSEcCtD
Ceftibuten—Flatulence—Cisplatin—bone cancer	0.0092	0.0092	CcSEcCtD
Ceftibuten—Renal impairment—Epirubicin—bone cancer	0.00836	0.00836	CcSEcCtD
Ceftibuten—Irritability—Methotrexate—bone cancer	0.00812	0.00812	CcSEcCtD
Ceftibuten—Convulsion—Cisplatin—bone cancer	0.00809	0.00809	CcSEcCtD
Ceftibuten—Renal impairment—Doxorubicin—bone cancer	0.00774	0.00774	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00766	0.00766	CcSEcCtD
Ceftibuten—Anaphylactic shock—Cisplatin—bone cancer	0.00762	0.00762	CcSEcCtD
Ceftibuten—Dehydration—Epirubicin—bone cancer	0.0074	0.0074	CcSEcCtD
Ceftibuten—Anorexia—Cisplatin—bone cancer	0.00726	0.00726	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00717	0.00717	CcSEcCtD
Ceftibuten—Pancytopenia—Methotrexate—bone cancer	0.00698	0.00698	CcSEcCtD
Ceftibuten—Dysuria—Methotrexate—bone cancer	0.00687	0.00687	CcSEcCtD
Ceftibuten—Neutropenia—Methotrexate—bone cancer	0.00687	0.00687	CcSEcCtD
Ceftibuten—Dehydration—Doxorubicin—bone cancer	0.00685	0.00685	CcSEcCtD
Ceftibuten—Paraesthesia—Cisplatin—bone cancer	0.00684	0.00684	CcSEcCtD
Ceftibuten—Dyspnoea—Cisplatin—bone cancer	0.00679	0.00679	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00663	0.00663	CcSEcCtD
Ceftibuten—Decreased appetite—Cisplatin—bone cancer	0.00662	0.00662	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Cisplatin—bone cancer	0.00658	0.00658	CcSEcCtD
Ceftibuten—Pancytopenia—Epirubicin—bone cancer	0.00653	0.00653	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.0065	0.0065	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—bone cancer	0.00644	0.00644	CcSEcCtD
Ceftibuten—Neutropenia—Epirubicin—bone cancer	0.00643	0.00643	CcSEcCtD
Ceftibuten—Dysuria—Epirubicin—bone cancer	0.00643	0.00643	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—bone cancer	0.00625	0.00625	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—bone cancer	0.00612	0.00612	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00608	0.00608	CcSEcCtD
Ceftibuten—Pancytopenia—Doxorubicin—bone cancer	0.00605	0.00605	CcSEcCtD
Ceftibuten—Renal failure—Epirubicin—bone cancer	0.00603	0.00603	CcSEcCtD
Ceftibuten—Body temperature increased—Cisplatin—bone cancer	0.00602	0.00602	CcSEcCtD
Ceftibuten—Jaundice—Epirubicin—bone cancer	0.00598	0.00598	CcSEcCtD
Ceftibuten—Neutropenia—Doxorubicin—bone cancer	0.00595	0.00595	CcSEcCtD
Ceftibuten—Dysuria—Doxorubicin—bone cancer	0.00595	0.00595	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—bone cancer	0.00591	0.00591	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—bone cancer	0.00588	0.00588	CcSEcCtD
Ceftibuten—Haematuria—Epirubicin—bone cancer	0.00585	0.00585	CcSEcCtD
Ceftibuten—Agranulocytosis—Epirubicin—bone cancer	0.00573	0.00573	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00563	0.00563	CcSEcCtD
Ceftibuten—Hypersensitivity—Cisplatin—bone cancer	0.00561	0.00561	CcSEcCtD
Ceftibuten—Renal failure—Doxorubicin—bone cancer	0.00558	0.00558	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—bone cancer	0.00556	0.00556	CcSEcCtD
Ceftibuten—Haemoglobin—Epirubicin—bone cancer	0.00554	0.00554	CcSEcCtD
Ceftibuten—Jaundice—Doxorubicin—bone cancer	0.00553	0.00553	CcSEcCtD
Ceftibuten—Haemorrhage—Epirubicin—bone cancer	0.00551	0.00551	CcSEcCtD
Ceftibuten—Asthenia—Cisplatin—bone cancer	0.00547	0.00547	CcSEcCtD
Ceftibuten—Haematuria—Doxorubicin—bone cancer	0.00541	0.00541	CcSEcCtD
Ceftibuten—Agranulocytosis—Doxorubicin—bone cancer	0.0053	0.0053	CcSEcCtD
Ceftibuten—Chills—Methotrexate—bone cancer	0.00528	0.00528	CcSEcCtD
Ceftibuten—Diarrhoea—Cisplatin—bone cancer	0.00521	0.00521	CcSEcCtD
Ceftibuten—Erythema multiforme—Epirubicin—bone cancer	0.00521	0.00521	CcSEcCtD
Ceftibuten—Haemoglobin—Doxorubicin—bone cancer	0.00512	0.00512	CcSEcCtD
Ceftibuten—Haemorrhage—Doxorubicin—bone cancer	0.0051	0.0051	CcSEcCtD
Ceftibuten—Dysgeusia—Methotrexate—bone cancer	0.00502	0.00502	CcSEcCtD
Ceftibuten—Chills—Epirubicin—bone cancer	0.00494	0.00494	CcSEcCtD
Ceftibuten—Vomiting—Cisplatin—bone cancer	0.00484	0.00484	CcSEcCtD
Ceftibuten—Erythema multiforme—Doxorubicin—bone cancer	0.00482	0.00482	CcSEcCtD
Ceftibuten—Rash—Cisplatin—bone cancer	0.0048	0.0048	CcSEcCtD
Ceftibuten—Dermatitis—Cisplatin—bone cancer	0.0048	0.0048	CcSEcCtD
Ceftibuten—Flatulence—Epirubicin—bone cancer	0.00472	0.00472	CcSEcCtD
Ceftibuten—Dysgeusia—Epirubicin—bone cancer	0.00469	0.00469	CcSEcCtD
Ceftibuten—Chills—Doxorubicin—bone cancer	0.00457	0.00457	CcSEcCtD
Ceftibuten—Nausea—Cisplatin—bone cancer	0.00453	0.00453	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—bone cancer	0.00444	0.00444	CcSEcCtD
Ceftibuten—Agitation—Epirubicin—bone cancer	0.00441	0.00441	CcSEcCtD
Ceftibuten—Flatulence—Doxorubicin—bone cancer	0.00437	0.00437	CcSEcCtD
Ceftibuten—Dysgeusia—Doxorubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—bone cancer	0.00418	0.00418	CcSEcCtD
Ceftibuten—Convulsion—Epirubicin—bone cancer	0.00415	0.00415	CcSEcCtD
Ceftibuten—Agitation—Doxorubicin—bone cancer	0.00408	0.00408	CcSEcCtD
Ceftibuten—Dry mouth—Epirubicin—bone cancer	0.00399	0.00399	CcSEcCtD
Ceftibuten—Anorexia—Methotrexate—bone cancer	0.00399	0.00399	CcSEcCtD
Ceftibuten—Anaphylactic shock—Epirubicin—bone cancer	0.00391	0.00391	CcSEcCtD
Ceftibuten—Convulsion—Doxorubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Ceftibuten—Insomnia—Methotrexate—bone cancer	0.00378	0.00378	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—bone cancer	0.00375	0.00375	CcSEcCtD
Ceftibuten—Anorexia—Epirubicin—bone cancer	0.00373	0.00373	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—bone cancer	0.00373	0.00373	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—bone cancer	0.00372	0.00372	CcSEcCtD
Ceftibuten—Dry mouth—Doxorubicin—bone cancer	0.00369	0.00369	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—bone cancer	0.00368	0.00368	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—bone cancer	0.00363	0.00363	CcSEcCtD
Ceftibuten—Anaphylactic shock—Doxorubicin—bone cancer	0.00362	0.00362	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—bone cancer	0.00361	0.00361	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—bone cancer	0.0036	0.0036	CcSEcCtD
Ceftibuten—Insomnia—Epirubicin—bone cancer	0.00354	0.00354	CcSEcCtD
Ceftibuten—Paraesthesia—Epirubicin—bone cancer	0.00351	0.00351	CcSEcCtD
Ceftibuten—Dyspnoea—Epirubicin—bone cancer	0.00349	0.00349	CcSEcCtD
Ceftibuten—Somnolence—Epirubicin—bone cancer	0.00348	0.00348	CcSEcCtD
Ceftibuten—Anorexia—Doxorubicin—bone cancer	0.00345	0.00345	CcSEcCtD
Ceftibuten—Dyspepsia—Epirubicin—bone cancer	0.00344	0.00344	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—bone cancer	0.00342	0.00342	CcSEcCtD
Ceftibuten—Decreased appetite—Epirubicin—bone cancer	0.0034	0.0034	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Epirubicin—bone cancer	0.00338	0.00338	CcSEcCtD
Ceftibuten—Fatigue—Epirubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Ceftibuten—Constipation—Epirubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—bone cancer	0.00332	0.00332	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—bone cancer	0.00331	0.00331	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—bone cancer	0.00331	0.00331	CcSEcCtD
Ceftibuten—Insomnia—Doxorubicin—bone cancer	0.00327	0.00327	CcSEcCtD
Ceftibuten—Paraesthesia—Doxorubicin—bone cancer	0.00325	0.00325	CcSEcCtD
Ceftibuten—Dyspnoea—Doxorubicin—bone cancer	0.00323	0.00323	CcSEcCtD
Ceftibuten—Somnolence—Doxorubicin—bone cancer	0.00322	0.00322	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Epirubicin—bone cancer	0.0032	0.0032	CcSEcCtD
Ceftibuten—Dyspepsia—Doxorubicin—bone cancer	0.00319	0.00319	CcSEcCtD
Ceftibuten—Decreased appetite—Doxorubicin—bone cancer	0.00315	0.00315	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00313	0.00313	CcSEcCtD
Ceftibuten—Fatigue—Doxorubicin—bone cancer	0.00312	0.00312	CcSEcCtD
Ceftibuten—Urticaria—Epirubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Ceftibuten—Constipation—Doxorubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Ceftibuten—Body temperature increased—Epirubicin—bone cancer	0.00309	0.00309	CcSEcCtD
Ceftibuten—Abdominal pain—Epirubicin—bone cancer	0.00309	0.00309	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—bone cancer	0.00308	0.00308	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—bone cancer	0.003	0.003	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Doxorubicin—bone cancer	0.00296	0.00296	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—bone cancer	0.00296	0.00296	CcSEcCtD
Ceftibuten—Hypersensitivity—Epirubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Ceftibuten—Urticaria—Doxorubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Ceftibuten—Body temperature increased—Doxorubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Ceftibuten—Abdominal pain—Doxorubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—bone cancer	0.00286	0.00286	CcSEcCtD
Ceftibuten—Asthenia—Epirubicin—bone cancer	0.00281	0.00281	CcSEcCtD
Ceftibuten—Pruritus—Epirubicin—bone cancer	0.00277	0.00277	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—bone cancer	0.00276	0.00276	CcSEcCtD
Ceftibuten—Diarrhoea—Epirubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Ceftibuten—Hypersensitivity—Doxorubicin—bone cancer	0.00267	0.00267	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—bone cancer	0.00266	0.00266	CcSEcCtD
Ceftibuten—Rash—Methotrexate—bone cancer	0.00264	0.00264	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—bone cancer	0.00263	0.00263	CcSEcCtD
Ceftibuten—Headache—Methotrexate—bone cancer	0.00262	0.00262	CcSEcCtD
Ceftibuten—Asthenia—Doxorubicin—bone cancer	0.0026	0.0026	CcSEcCtD
Ceftibuten—Dizziness—Epirubicin—bone cancer	0.00259	0.00259	CcSEcCtD
Ceftibuten—Pruritus—Doxorubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Ceftibuten—Vomiting—Epirubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—bone cancer	0.00248	0.00248	CcSEcCtD
Ceftibuten—Diarrhoea—Doxorubicin—bone cancer	0.00248	0.00248	CcSEcCtD
Ceftibuten—Rash—Epirubicin—bone cancer	0.00247	0.00247	CcSEcCtD
Ceftibuten—Dermatitis—Epirubicin—bone cancer	0.00246	0.00246	CcSEcCtD
Ceftibuten—Headache—Epirubicin—bone cancer	0.00245	0.00245	CcSEcCtD
Ceftibuten—Dizziness—Doxorubicin—bone cancer	0.00239	0.00239	CcSEcCtD
Ceftibuten—Nausea—Epirubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Ceftibuten—Vomiting—Doxorubicin—bone cancer	0.0023	0.0023	CcSEcCtD
Ceftibuten—Rash—Doxorubicin—bone cancer	0.00228	0.00228	CcSEcCtD
Ceftibuten—Dermatitis—Doxorubicin—bone cancer	0.00228	0.00228	CcSEcCtD
Ceftibuten—Headache—Doxorubicin—bone cancer	0.00227	0.00227	CcSEcCtD
Ceftibuten—Nausea—Doxorubicin—bone cancer	0.00215	0.00215	CcSEcCtD
